Carotid Artery Stiffness is Associated With Cognitive Performance in Former Smokers With and Without Chronic Obstructive Pulmonary Disease

Karin F Hoth, Kerrie L Moreau, Howard D Weinberger, Kristen E Holm, Kimberly Meschede, James D Crapo, Barry J Make, David J Moser, Elizabeth Kozora, Russell P Bowler, Gary L Pierce, Patrick Ten Eyck, Frederick S Wamboldt, Karin F Hoth, Kerrie L Moreau, Howard D Weinberger, Kristen E Holm, Kimberly Meschede, James D Crapo, Barry J Make, David J Moser, Elizabeth Kozora, Russell P Bowler, Gary L Pierce, Patrick Ten Eyck, Frederick S Wamboldt

Abstract

Background Heavy smokers perform worse on neuropsychological assessment than age-matched peers. However, traditional pulmonary measures of airflow limitation and hypoxemia explain only a modest amount of variance in cognition. The current objective was to determine whether carotid artery stiffness is associated with cognition in former smokers beyond the effects of amount of smoking and pulmonary function. Methods and Results Eighty-four former smokers including individuals across a spectrum of airflow limitation severity were included: 30 without chronic obstructive pulmonary disease (Global Initiative for Chronic Obstructive Lung Disease [GOLD] 0 with normal spirometry and lung computed tomography), 31 with mild-moderate chronic obstructive pulmonary disease (GOLD 1-2), and 23 with severe-very severe chronic obstructive pulmonary disease (GOLD 3-4). Participants completed questionnaires, spirometry, carotid ultrasonography, and neuropsychological testing. Multiple linear regression was used to determine whether carotid artery stiffness is associated with neuropsychological performance in 4 cognitive domains after adjusting for age, sex, pack-years of smoking, estimated premorbid intellectual functioning, and airflow limitation. Higher carotid artery β-stiffness index was associated with reduced executive functioning-processing speed in the fully adjusted model (β=-0.49, SE=0.14; P=0.001). Lower premorbid intellectual function, male sex, and presence of airflow limitation (GOLD 1 or 2 and GOLD 3 or 4) were also associated with worse executive functioning-processing speed. β-Stiffness index was not significantly associated with performance in other cognitive domains. Conclusions Carotid artery stiffness is associated with worse performance on executive functioning-processing speed in former smokers beyond the effects of aging, amount of past smoking, severity of airflow limitation, and hypoxemia. Future research should examine whether carotid stiffness can be used to identify former smokers at risk for subsequent cognitive impairment.

Trial registration: ClinicalTrials.gov NCT00608764.

Keywords: carotid artery stiffness; chronic obstructive pulmonary disease; cognition; smoking.

Figures

Figure 1
Figure 1
Study activities by visit.
Figure 2
Figure 2
Scatterplot of the association between central artery stiffness and executive function‐processing speed in former smokers.

References

    1. Swan GE, Lessov‐Schlaggar CN. The effects of tobacco smoke and nicotine on cognition and the brain. Neuropsychol Rev. 2007;17:259–273.
    1. Starr JM, Deary IJ, Fox HC, Whalley LJ. Smoking and cognitive change from age 11 to 66 years: a confirmatory investigation. Addict Behav. 2007;32:63–68.
    1. Durazzo TC, Meyerhoff DJ, Nixon SJ. A comprehensive assessment of neurocognition in middle‐aged chronic cigarette smokers. Drug Alcohol Depend. 2012;122:105–111.
    1. Ott A, Andersen K, Dewey ME, Letenneur L, Brayne C, Copeland JR, Dartigues JF, Kragh‐Sorensen P, Lobo A, Martinez‐Lage JM, et al. Effect of smoking on global cognitive function in nondemented elderly. Neurology. 2004;62:920–924.
    1. Paul RH, Brickman AM, Cohen RA, Williams LM, Niaura R, Pogun S, Clark CR, Gunstad J, Gordon E. Cognitive status of young and older cigarette smokers: data from the international brain database. J Clin Neurosci. 2006;13:457–465.
    1. Singh B, Mielke MM, Parsaik AJ, Cha RH, Roberts RO, Scanlon PD, Geda YE, Christianson TJ, Pankratz VS, Peterson RC. A prospective study of chronic obstructive pulmonary disease and the risk for mild cognitive impairment. JAMA Neurol. 2014;71:581–588.
    1. Prigatano GP, Parsons O, Wright E, Levin DC, Hawryluk G. Neuropsychological test performance in mildly hypoxemic patients with chronic obstructive pulmonary diseae. J Consult Clin Psychol. 1983;51:108–116.
    1. Yohannes AM. Cognitive impairment and risk for disability in chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2014;11:1445–1446.
    1. Bajaj MK, Burrage DR, Tappouni A, Dodd JW, Jones PW, Baker EH. COPD patients hospitalized with exacerbations have greater cognitive impairment than patients hospitalized with decompensated heart failure. Clin Interv Aging. 2019;14:1–8.
    1. Antonelli‐Incalzi R, Corsonello A, Pedone C, Trojano L, Acanfora D, Spada A, Izzo O, Rengo F. Drawing impairment predicts mortality in severe COPD. Chest. 2006;130:1687–1694.
    1. Baird C, Lovell J, Johnson M, Shiell K, Ibrahim JE. The impact of cognitive impairment on self‐management in chronic obstructive pulmonary disease: a systematic review. Respir Med. 2017;129:130–139.
    1. Sulaiman I, Cushen B, Greene G, Seheult J, Seow D, Rawat F, MacHale E, Mokoka M, Moran CN, Sartini Bhreathnach A, et al. Objective assessment of adherence to inhalers by patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2017;195:1333–1343.
    1. Dodd JW, Chung AW, van den Broek MD, Barrick TR, Charlton RA, Jones PW. Brain structure and function in chronic obstructive pulmonary disease: a multimodal cranial magnetic resonance imaging study. Am J Respir Crit Care Med. 2012;186:240–245.
    1. Wen XH, Li Y, Han D, Sun L, Ren PX, Ren D. The relationship between cognitive function and arterial partial pressure O2 in patients with COPD: a meta‐analysis. Medicine (Baltimore). 2018;97:e9599.
    1. Liesker JJ, Postma DS, Beukema RJ, ten Hacken NH, van der Molen T, Riemersma RA, van Zomeren EH, Kerstjens HA. Cognitive performance in patients with COPD. Respir Med. 2004;98:351–356.
    1. McDonough JE, Yuan R, Suzuki M, Seyednejad N, Elliott WM, Sanchez PG, Wright AC, Gefter WB, Litzky L, Coxson HO, et al. Small‐airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med. 2011;365:1567–1575.
    1. Alford SK, van Beek EJ, McLennan G, Hoffman EA. Heterogeneity of pulmonary perfusion as a mechanistic image‐based phenotype in emphysema susceptible smokers. Proc Natl Acad Sci USA. 2010;107:7485–7490.
    1. Barr RG. The epidemiology of vascular dysfunction relating to chronic obstructive pulmonary disease and emphysema. Proc Am Thorac Soc. 2011;8:522–527.
    1. Sabit R, Shale DJ. Vascular structure and function in chronic obstructive pulmonary disease: a chicken and egg issue? Am J Respir Crit Care Med. 2007;176:1175–1176.
    1. Blum A, Simsolo C, Sirchan R. Vascular responsiveness in patients with chronic obstructive pulmonary disease (COPD). Eur J Intern Med. 2014;25:370–373.
    1. Brusselle G, Bracke K, De Pauw M. Peripheral artery disease in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2017;195:148–150.
    1. Borson S, Scanlan J, Friedman S, Zuhr E, Fields J, Aylward E, Mahurin R, Richards T, Anzai Y, Yukawa M, et al. Modeling the impact of COPD on the brain. Int J Chron Obstruct Pulmon Dis. 2008;3:429–434.
    1. Dodd JW. Lung disease as a determinant of cognitive decline and dementia. Alzheimers Res Ther. 2015;7:32.
    1. Lahousse L, Tiemeier H, Ikram MA, Brusselle GC. Chronic obstructive pulmonary disease and cerebrovascular disease: a comprehensive review. Respir Med. 2015;109:1371–1380.
    1. van Sloten TT, Protogerou AD, Henry RM, Schram MT, Launer LJ, Stehouwer CD. Association between arterial stiffness, cerebral small vessel disease and cognitive impairment: a systematic review and meta‐analysis. Neurosci Biobehav Rev. 2015;53:121–130.
    1. Cui C, Sekikawa A, Kuller LH, Lopez OL, Newman AB, Kuipers AL, Mackey RH. Aortic stiffness is associated with increased risk of incident dementia in older adults. J Alzheimers Dis. 2018;66:297–306.
    1. Pase MP, Himali JJ, Mitchell GF, Beiser A, Maillard P, Tsao C, Larson MG, DeCarli C, Vasan RS, Seshadri S. Association of aortic stiffness with cognition and brain aging in young and middle‐aged adults: the Framingham Third Generation Cohort Study. Hypertension. 2016;67:513–519.
    1. Li X, Lyu P, Ren Y, An J, Dong Y. Arterial stiffness and cognitive impairment. J Neurol Sci. 2017;380:1–10.
    1. Meyer ML, Palta P, Tanaka H, Deal JA, Wright J, Knopman DS, Griswold ME, Mosley TH, Heiss G. Association of central arterial stiffness and pressure pulsatility with mild cognitive impairment and dementia: the Atherosclerosis Risk in Communities Study‐Neurocognitive Study (ARIC‐NCS). J Alzheimers Dis. 2017;57:195–204.
    1. Pase MP, Herbert A, Grima NA, Pipingas A, O'Rourke MF. Arterial stiffness as a cause of cognitive decline and dementia: a systematic review and meta‐analysis. Intern Med J. 2012;42:808–815.
    1. Mitchell GF, Van Buchem MA, Sigurdsson S, Gotal JD, Jonsdottir MK, Kjartansson O, Garcia M, Aspelund T, Harris TB, Gundnason V, et al. Arterial stiffness, pressure and flow pulsatility and brain structure and function: the, Age, Gene/Environment Susceptibility—Reykjavik Study. Brain. 2011;134:3398–3407.
    1. Tsao CW, Himali JJ, Beiser AS, Larson MG, DeCarli C, Vasan RS, Mitchell GF, Seshadri S. Association of arterial stiffness with progression of subclinical brain and cognitive disease. Neurology. 2016;86:619–626.
    1. Hamasaki A, Akazawa N, Yoshikawa T, Myoenzono K, Tagawa K, Sawano Y, Nishimura M, Maeda S. Central artery stiffness is related to cerebral oxygenation hemodynamics during executive function tasks in healthy middle‐aged and older adults. Exp Gerontol. 2018;114:93–98.
    1. Palta P, Sharrett AR, Wei J, Meyer ML, Kucharska‐Newton A, Power MC, Deal JA, Jack CR, Knopman D, Wright J, et al. Central arterial stiffness is associated with structural brain damage and poorer cognitive performance: the ARIC Study. J Am Heart Assoc. 2019;8:e011045 DOI: 10.1161/JAHA.118.011045
    1. Dixon K, LaMonica H, Duffy SL, Phillips CL, Grunstein RR, Naismith SL, Hoyos CM. Arterial stiffness relates to executive dysfunction in later life. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2020;27:140–151.
    1. DuBose LE, Voss MW, Weng TB, Kent JD, Dubishar KM, Lane‐Cordova A, Sigurdsson G, Schmid P, Barlow PB, Pierce GL. Carotid beta‐stiffness index is associated with slower processing speed but not working memory or white matter integrity in healthy middle‐aged/older adults. J Appl Physiol (1985). 2017;122:868–876.
    1. Regan EA, Hokanson JE, Murphy JR, Make B, Lynch DA, Beaty TH, Curran‐Everett D, Silverman EK, Crapo JD. Genetic epidemiology of COPD (COPDGene) study design. COPD. 2010;7:32–43.
    1. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, et al. Standardisation of spirometry. Eur Respir J. 2005;26:319–338.
    1. Global Initiative for Chronic Obstructive Lung Disease . Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2019.
    1. Tanaka H, Dinenno FA, Monahan KD, Clevenger CM, DeSouza CA, Seals DR. Aging, habitual exercise, and dynamic arterial compliance. Circulation. 2000;102:1270–1275.
    1. Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation. 1986;74:1399–1406.
    1. Moreau KL, Meditz A, Deane KD, Kohrt WM. Tetrahydrobiopterin improves endothelial function and decreases arterial stiffness in estrogen‐deficient postmenopausal women. Am J Physiol Heart Circ Physiol. 2012;302:H1211–H1218.
    1. Moreau KL, Donato AJ, Seals DR, DeSouza CA, Tanaka H. Regular exercise, hormone replacement therapy and the age‐related decline in carotid arterial compliance in healthy women. Cardiovasc Res. 2003;57:861–868.
    1. Roman MJ, Pickering TG, Schwartz JE, Pini R, Devereux RB. Relation of arterial structure and function to left ventricular geometric patterns in hypertensive adults. J Am Coll Cardiol. 1996;28:751–756.
    1. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361–370.
    1. Sutton K, Cooper M, Pimm J, Wallace L. Anxiety in chronic obstructive pulmonary disease: the role of illness specific catastrophic thoughts. Cognit Ther Res. 1999;23:573–585.
    1. Hajiro TK, Nishimura M, Tsukino M, Ikeda A, Oga T. Stages of disease severity and factors that affect the health status of patients with chronic obstructive pulmonary disease. Respir Med. 2000;94:841–846.
    1. Okubadejo AA, Jones PW, Wedzicha JA. Quality of life in patients with chronic obstructive pulmonary disease and severe hypozaemia. Thorax. 1996;51:44–47.
    1. Folstein MF, Folstein SE, White T, Messer MA. Mini‐Mental State Examination, 2nd Edition (MMSE‐2). Lutz, FL: Psychological Assessment Resources; 2010.
    1. Frazen MD, Burgess EJ, Smith‐Seemiller L. Methods of estimating premorbid functioning. Arch Clin Neuropsychol. 1997;12:711–738.
    1. Griffin SL, Mindt MR, Rankin EJ, Ritchie AJ, Scott AS. Estimating premorbid intelligence: comparison of traditional and contemporary methods across the intellignece continuum. Arch Clin Neuropsychol. 2002;17:497–507.
    1. Johnstone B, Callahan CD, Kapila CJ, Bouman DE. The comparability of the WRAT‐R reading test and NAART as estimates of premorbid intelligence in neurologically impaired patients. Arch Clin Neuropsychol. 1996;11:513–519.
    1. Wikinson GS, Robertson GJ. Wide Range Achievement Test 4 Professional Manual. Lutz, FL: Psychological Assessment Resources; 2006.
    1. Davis AS, Pierson EE. The relationship between the WAIS‐III digit symbol coding and executive functioning. Appl Neuropsychol Adult. 2012;19:192–197.
    1. Aita SL, Beach JD, Taylor SE, Borgogna NC, Harrell MN, Hill BD. Executive, language, or both? An examination of the construct validity of verbal fluency measures. Appl Neuropsychol Adult. 2019;26:441–451.
    1. Alosco ML, Garcia S, Spitznagel MB, van Dulmen M, Cohen R, Sweet LH, Josephson R, Hughes J, Rosneck J, Gunstad J. Cognitive performance in older adults with stable heart failure: longitudinal evidence for stability and improvement. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2014;21:239–256.
    1. Paul RH, Cooley SA, Garcia‐Egan PM, Ances BM. Cognitive performance and frailty in older HIV‐positive adults. J Acquir Immune Defic Syndr. 2018;79:375–380.
    1. Tombaugh T, Rees L, McIntyre N. Normative Data for the Trail Making Test. Personal Communication. New York, NY: Oxford University Press; 1998.
    1. Tombaugh T, Kozak J, Rees L. Normative data for the controlled oral word association test In: Spreen O, Strauss E, eds. Compendium of Neuropsychological Tests. 2nd ed New York, NY: Oxford University Press; 1998:455.
    1. Golden C, Freshwater S. Stroop Color and Word Test: Revised Examiner's Manual. Wood Dale, IL: Stolting Co.; 2002.
    1. Wechsler D. Wechsler Adult Intelligence Scale‐Fourth Edition. San Antonio, TX: Pearson Assessment; 2008.
    1. Delis DC, Kramer JH, Kaplan E, Ober BA. California Verbal Learning Test‐Second Edition Adult Version (CVLT‐II). 2nd ed San Antonio, TX: Pearson Clinical Assessment; 2000.
    1. Benedict R. Brief Visuospatial Memory Test‐Revised. Odessa, FL: Psychological Assessment Resources; 1994.
    1. Kaplan E, Goodglass H, Weintraub S. Boston Naming Test. Philadelphia, PA: Lea and Febiger; 1983.
    1. Gladsjo JA, Schuman CC, Evans JD, Peavy GM, Miller SW, Heaton RK. Norms for letter and category fluency: demographic corrections for age, education, and ethnicity. Assessment. 1999;6:147–178.
    1. The Hooper Visual Organization Test. Los Angeles, CA: Western Psychological Services; 1983.
    1. Chirinos JA, Segers P, Hughes T, Townsend R. Large‐artery stiffness in health and disease: JACC state‐of‐the‐art review. J Am Coll Cardiol. 2019;74:1237–1263.
    1. Gorelick PB, Scuteri A, Black SE, Decarli C, Greenberg SM, Iadecola C, Launer LJ, Laurent S, Lopez OL, Nyenhuis D, et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42:2672–2713.
    1. Tsao CW, Seshadri S, Beiser AS, Westwood AJ, DeCarli CD, Au R, Himali JJ, Hamburg NM, Vita JA. Relations of arterial stiffness and endothelial function to brain aging in the community. Neurology. 2013;81:984–991.
    1. Jurasic MJ, Popovic IM, Morovic S, Trkanjec Z, Seric V, Demarin V. Can beta stiffness index be proposed as a risk factor for dementia. J Neurol Sci. 2009;283:13–16.
    1. Steward KA, Pasha E, Goudarzi K, Elmenshawy A, Alkatan M, Villalpando A, Tanaka H, Haley AP. Midlife arterial stiffness and brain activation during working memory task. Open Hypertens J. 2014;5:3–9.
    1. Kearney‐Schwartz A, Rossignol P, Bracard S, Felblinger J, Fay R, Boivin JM, Lecompte T, Lacolley P, Benetos A, Zannad F. Vascular structure and function is correlated to cognitive performance and white matter hyperintensities in older hypertensive patients with subjective memory complaints. Stroke. 2009;40:1229–1236.
    1. Henskens LH, Kroon AA, van Oostenbrugge RJ, Gronenschild EH, Fuss‐Lejeune MM, Hofman PA, Lodder J, de Leeuw PW. Increased aortic pulse wave velocity is associated with silent cerebral small‐vessel disease in hypertensive patients. Hypertension. 2008;52:1120–1126.
    1. Moody DM, Bell MA, Challa VR. Features of the cerebral vascular pattern that predict vulnerability to perfusion or oxygenation deficiency: an anatomic study. AJNR Am J Neuroradiol. 1990;11:431–439.
    1. Bowler JV, Steenhuis R, Hachinski V. Conceptual background to vascular cognitive impairment. Alzheimer Dis Assoc Disord. 1999;13(suppl 3):S30–S37.
    1. Vasquez BP, Zakzanis KK. The neuropsychological profile of vascular cognitive impairment not demented: a meta‐analysis. J Neuropsychol. 2015;9:109–136.
    1. Hildreth KL, Barry DW, Moreau KL, Vande Griend J, Meacham RB, Nakamura T, Wolfe P, Kohrt WM, Ruscin JM, Kittelson J, et al. Effects of testosterone and progressive resistance exercise in healthy, highly functioning older men with low‐normal testosterone levels. J Clin Endocrinol Metab. 2013;98:1891–1900.
    1. Hougaku H, Fleg JL, Najjar SS, Lakatta EG, Harman SM, Blackman MR, Metter EJ. Relationship between androgenic hormones and arterial stiffness, based on longitudinal hormone measurements. Am J Physiol Endocrinol Metab. 2006;290:E234–E242.
    1. Dransfield MT, Cockcroft JR, Townsend RR, Coxson HO, Sharma SS, Rubin DB, Emmett AH, Cicale MJ, Crater GD, Martinez FJ. Effect of fluticasone propionate/salmeterol on arterial stiffness in patients with COPD. Eur Respir J. 2011;105:1322–1330.
    1. Sabit RBC, Allanby C, Cockcroft JR, Shale DJ. Arterial stiffness is reduced by combination inhaled corticosteroid/long acing beta‐2 agonist therapy in pateints with COPD. Thorax. 2007;62:142.
    1. Vivodtzev I, Minet C, Wuyam B, Borel JC, Vottero G, Monneret D, Baguet JP, Levy P, Pepin JL. Significant improvement in arterial stiffness after endurance training in patients with COPD. Chest. 2010;137:585–592.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner